During the past decade, Jilin Province People's Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 7 clinical trials were completed, i.e. on average, 21.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 5 clinical trials were completed. i.e. 31.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jilin Province People's Hospital" #1 sponsor was "Beijing Tiantan Hospital" with 5 trials, followed by "Takeda" with 5 trials sponsored, "Bayer" with 3 trials sponsored, "China Academy of Chinese Medical Sciences" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jilin Province People's Hospital" #1 collaborator was "China Food and Drug Administration" with 2 trials as a collaborator, "Guangzhou Recomgen Biotech Co., Ltd." with 2 trials as a collaborator, "Jilin Province People's Hospital" with 2 trials as a collaborator, "Ankang City Central Hospital" with 1 trials as a collaborator and "Baotou Central Hospital" with 1 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Jilin Province People's Hospital" are "Acute Ischemic Stroke" (3 trials), "Stroke" (3 trials), "Acute Stroke" (2 trials), "Erosive Esophagitis" (2 trials) and "Transient Ischemic Attack" (2 trials). Many other conditions were trialed in "Jilin Province People's Hospital" in a lesser frequency.

Most popular intervention types in "Jilin Province People's Hospital" are "Drug" (34 trials), "Other" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lansoprazole" (4 trials), "Lansoprazole Placebo" (4 trials), "Bismuth-Containing Quadruple Therapy" (2 trials) and "Danhong injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jilin Province People's Hospital" are 36 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jilin Province People's Hospital". 1 are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Jilin Province People's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Jilin Province People's Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".